Russian sputnik's vaccine is 92% effective against Covid-19

A new trial of Covid-19 vaccines made by Russian pharmaceutical giant, Sputnik, has revealed 92% efficacy against the deadly Coronavirus disease.

The vaccine which has been deemed save for administration was initially met with some controversy after being rolled out before the final trial data had been released.

It joins the likes of other proven vaccines including Pfizer, Oxford/AstraZeneca, Moderna and Janssen, after been given nods by scientists.

According to the latest trial, no serious reaction is linked to the vaccine, even though minor after used effect like sore arm, tiredness and a bit of a temperature are expected.

And there were no deaths or serious illness in the vaccinated group linked to the jab.